Project Creatine’s Creatine Monohydrate Capsules made with CreaXorb™, creatine monohydrate in a self emulsifying delivery system. The difference is in the formulation, bringing creatine and a specialized delivery system together in convenient capsules.
A human pharmacokinetic study summary reports higher blood creatine exposure with CreaXorb™ than with conventional creatine monohydrate under the study conditions.
No powder to measure or mix. Discover the research below or learn more about BioSNEDS technology.
Research on Creatine Delivery
A human pharmacokinetic study summary reports higher blood creatine exposure with CreaXorb™ than with conventional creatine monohydrate under the study conditions.
These findings concern blood creatine exposure. They do not establish equivalent doses or improved strength, recovery, or cognitive performance.
The novel BioSNED CreaXorb™ formulation demonstrated significantly enhanced bioavailability compared to conventional Creatine Monohydrate, with a relative bioavailability coefficient of 22, indicating 2200% superior absorption characteristics and potential therapeutic advantages.
Pharmacokinetic Evaluation of Novel BioSNEDS CreaXorb™ Formulation: A Randomized Crossover Investigation
Project Creatine combines creatine monohydrate with CreaXorb™, powered by BioSNEDS® self-emulsifying delivery technology. This formulation brings the ingredient and its delivery system together in a convenient capsule.
No scooping, mixing, or flavored powders. Just a simple addition to your daily routine.
CreaXorb™ LSME
1,140 mg per serving.
Other Ingredients:
Vegetable cellulose (capsule), sunflower lecithin, coconut/palm fruit oils, glycine, vegetable glycerin, vegetable dextrin, rice hull fiber, silica, cane and beet sugar, citrus and berry extracts, and magnesium stearate.
Take 2 capsules daily with water or your preferred beverage, or as directed by a healthcare professional.
Directions
Evidence-based creatine guidance
